Researchers have used CRISPR-Cas9 to edit long-lived blood stem cells to reverse the clinical symptoms observed with several blood disorders, including sickle cell disease and beta-thalassemia.
from All Top News -- ScienceDaily https://ift.tt/2GRElXh
Here different kind of articles available for people, simple and easy tips related to different topics.
No comments:
Post a Comment